- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01762540
Glucocorticoid Induced Whole Body Catabolisme
Glucocorticoid Induced Inhibition of IGF-I Activity: Exploring Underlying Mechanisms.
Study Overview
Status
Intervention / Treatment
Detailed Description
Long-term treatment with glucocorticoid induces a general state of catabolism and increases insulin resistance. The underlying mechanisms are insufficiently characterized, however glucocorticoid induced changes of Growth Hormone (GH) and the Insulin-like growth factor I (IGF-I) appear to be of outmost importance.
We wish to investigate the mechanism behind glucocorticoid induced catabolism and insulin resistance.
More specific we wish to investigate:
- Whether glucocorticoid induces IGF-I inhibiting substances in serum or interstitial fluid that block the ability of IGF-I to phosphorylate its receptor in vitro
- Whether glucocorticoid inhibits intracellular IGF-I and insulin signaling in vitro and in vivo
- The mechanisms by which growth hormone counteracts the CG-mediated inhibition of IGF-I action
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Medical Research Laboratory, Clinical Institute of Medicine, Aarhus University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- signed and dated informed consent
- healthy subjects
- sex: male
- age 20-30 years
- BMI 19-26 kg/m2
- normal HbA1c
Exclusion Criteria:
- suspected og known allergy to the trial drug or similar medications.
- known current illness including diabetes mellitus, ischemic heart disease or cardiac arrhythmia.
- Daily drug intake (excluding Over-the-Counter medicines).
- Known or previous mental illness
- Current participation or previous participation in experiments using ionizing radiation for a year prior to inclusion in this study.
- Participation in a larger X-ray examinations in trial period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Calcium supplement
Capsule with tablet of calclium supplement
|
Placebo
Other Names:
|
ACTIVE_COMPARATOR: Glucocorticoids
Capsule with tablet of Prednisolone 37,5mg
|
Prednisolone 37.5 mg x1 for 5 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulin-like Growth Factor (IGF)-I profiles of subjects before and after prednisolone-treatment.
Time Frame: day 1, 3 and 5
|
Blood-test before (day 1) during (day 3) and at the end (day 5) of placebo/prednisolone treatment.
|
day 1, 3 and 5
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intracellular signaling of IGF-I under the influence/abscence of prednisolone.
Time Frame: day 5
|
Tissue biopsy on day 5.
|
day 5
|
Insulin sensitivity under the influence/abscence of prednisolone.
Time Frame: Day 5
|
Hyperinsulinemic euglycemic clamp on day 5.
|
Day 5
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jan Frystyk, Professor, Medical Research Laboratory, Clinical Institute of Medicine, Aarhus University Hospital
Publications and helpful links
General Publications
- Ramshanker N, Jessen N, Voss TS, Pedersen SB, Jorgensen JOL, Nielsen TS, Frystyk J, Moller N. Effects of short-term prednisolone treatment on indices of lipolysis and lipase signaling in abdominal adipose tissue in healthy humans. Metabolism. 2019 Oct;99:1-10. doi: 10.1016/j.metabol.2019.06.013. Epub 2019 Jun 29.
- Ramshanker N, Aagaard M, Hjortebjerg R, Voss TS, Moller N, Jorgensen JOL, Jessen N, Bjerring P, Magnusson NE, Bjerre M, Oxvig C, Frystyk J. Effects of Prednisolone on Serum and Tissue Fluid IGF-I Receptor Activation and Post-Receptor Signaling in Humans. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4031-4040. doi: 10.1210/jc.2017-00696.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GK_nilani_2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Whole Body Catabolisme Induced by Glucocorticoids
-
Universitaire Ziekenhuizen KU LeuvenUnknownNon-invasive | Gastro-intestinal Tumor | Accurate Staging | Whole-body Diffusion Weighted MRIBelgium
-
Maria Sklodowska-Curie National Research Institute...RecruitingRecurrent Soft Tissue Sarcoma | Recurrent Sarcoma | Radiation Induced Neoplasms | Radiation-Induced CancerPoland
-
Centre Hospitalier Universitaire, AmiensCompletedPrediction by the Synek Score of Poor Neurological Outcome in Postanoxic Comatose Patients Treated With Induced HypothermiaFrance
-
Universitaire Ziekenhuizen KU LeuvenUnknownMagnetic Resonance Imaging | Neurofibromatosis 1 | Whole Body Imaging | Diffusion Magnetic Resonance Imaging | Peripheral Nerve Sheath Tumors, MalignantBelgium
-
AmgenCompletedChemotherapy-induced Febrile NeutropeniaBelgium, Poland, Germany, Czechia, Austria, France, Greece, Romania, Bulgaria
-
Shin Poong Pharmaceutical Co. Ltd.CompletedLaparoscopy | Tissue Adhesion, Surgery-Induced | Leiomyoma of the Uterine BodyKorea, Republic of
-
Lei LiBeijing Hospital; China-Japan Friendship Hospital; Navy General Hospital, Beijing and other collaboratorsUnknownQuality of Life | Epithelial Ovarian Cancer | Chemotherapy-induced Neutropenia | Overall Survival | Progression-free Survival | Febrile Neutropenia, Drug-Induced | Colony Stimulating Factors Adverse Reaction | Granulocyte Colony Stimulating Factor | Cost-effectiveness AnalysisChina
-
University of PennsylvaniaMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's Disease | Myasthenia Gravis | Spinal Cord Injuries | Multiple System Atrophy | Progressive Supranuclear Palsy | Essential Tremor | Alzheimer's Disease | Diffuse Lewy Body Disease | Drug Induced Parkinson's DiseaseUnited States
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia
Clinical Trials on Calcium Supplement
-
University of MichiganCompletedDental CariesUnited States
-
National and Kapodistrian University of AthensNational Hellenic Research FoundationCompletedOsteopenia | Postmenopausal OsteopeniaGreece
-
Isfahan University of Medical SciencesUnknownNutritional and Metabolic DiseaseIran, Islamic Republic of
-
Ioannis K. Triantafyllopoulos, MD,MSci,PhDCompletedOsteopenia | Postmenopausal Osteopenia
-
Purdue UniversityCompletedOsteoporosisUnited States
-
Penn State UniversityCalifornia Dried Plum BoardActive, not recruiting
-
Eli Lilly and CompanyCompletedOsteoporosis, PostmenopausalUnited States, Belgium, Canada, Austria, Czech Republic, Denmark, Netherlands, New Zealand, Sweden, Finland, Argentina, Australia, Hungary, Israel, Italy, Norway, Poland
-
Siriraj HospitalActive, not recruitingHypocalcemia in PregnancyThailand
-
South Dakota State UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Eunice Kennedy Shriver National Institute of Child...Office of Dietary Supplements (ODS)Completed